Health News
Celexa and Risk of Arrhythmia
The U.S. Food and Drug Administration (FDA) is clarifying dosing and warning recommendations for the antidepressant Celexa ( citalopram hydrobromide ; also available in generic form).
Depression Common Among Stroke Survivors
Feeling a sense of disinterest or hopelessness after a stroke? It may be depression. Stroke or mini stroke survivors are more likely to become depressed as compared to the general population.
Depressed Stent Patients At Added Risk
Patients who receive coronary stents to prop open blocked arteries are at an added long-term risk of dying if they suffer from depression.
Chronic Depression Linked to Cognitive Decline in Heart Patients
Older coronary artery disease patients receiving cardiac catheterization who remain chronically depressed appear to be at a significantly increased risk of suffering from cognitive decline.
Working Overtime Doubles Depression
"All work and no play makes Jack a dull boy," goes the popular saying. Apparently, it also makes Jack a depressed boy. For people who work long hours, above the 40-hour-per-week average, the risk of becoming depressed is much greater.
A Shot for Sadness, Sluggishness, and Stroke
Those recently suffering a lacunar stroke should talk to their health care provider about vitamin supplementation, studies suggest.
Taking a Team Approach to Treatment
Chronic disorders impact millions of Americans. Treatment can sometimes be expensive, persistent, and ineffective. Recent research shows that a team approach to care can offer benefits.
Asleep at the Wheel
As if police officers did not already face enough dangers on the job, they can now add one more hazard to the list: a high incidence of sleep disorders.
FDA Drug Safety Communication: Celexa
The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and patients that the antidepressant Celexa ( citalopram hydrobromide ; also marketed as generics) should no longer be used at doses greater than 40 mg per day because it can cause abnormal changes in the electrical activity of the heart. Studies did not show a benefit in the treatment of depression at doses higher than 40 mg per day.
FDA Drug Safety Communication: Celexa
The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and patients that the antidepressant Celexa ( citalopram hydrobromide ; also marketed as generics) should no longer be used at doses greater than 40 mg per day because it can cause abnormal changes in the electrical activity of the heart. Studies did not show a benefit in the treatment of depression at doses higher than 40 mg per day.
Previously, the citalopram drug label stated that certain patients may require a dose of 60 mg per day.
Facts about Celexa ( citalopram hydrobromide )
Is in a cla...